The Wall Street Transcript > Search > Back Issues

Recent Reports

2010-03-22: Data Hosting & Data Storage Report
2 leading Analysts; and top management from 5 Sector Firms examine this vital industry in this 32 page report from The Wall Street Transcript.
More Information
Order this Report

2010-03-22: Retail Report
6 leading Analysts; and top management from 2 Sector Firms examine this vital industry in this 30 page report from The Wall Street Transcript.
More Information
Order this Report

2010-03-22: Socially Reponsible Investing & Investing Strategies Report
8 Money Managers examine this vital industry in this 43 page report from The Wall Street Transcript.
More Information
Order this Report

2010-03-11: Health Care IT Report
6 leading Analysts; and top management from 1 Sector Firm examine this vital industry in this 23 page report from The Wall Street Transcript.
More Information
Order this Report

2010-03-08: Business & Application Software Report
12 leading Analysts; and top management from 14 Sector Firms examine this vital industry in this 119 page report from The Wall Street Transcript.
More Information
Order this Report

2010-03-08: Pacific & Southwest Regional Banks Report
6 leading Analysts; and top management from 3 Sector Firms examine this vital industry in this 37 page report from The Wall Street Transcript.
More Information
Order this Report

Search TWST Online

Search by ticker:
or Sector:
Search by keyword:

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Subscribe to TWST

The Wall Street Transcript is a completely unique resource for investors and business researchers. Thousands of in-depth interviews with CEOs, Industry Analysts and Professional Money Managers going back 10 years.

To obtain a copy of a TWST issue/report order online or call (212) 952-7433 .

SUBSCRIBE

   

06.01.09: Biotechnology Report

1 roundtable forum, 1 analyst and 15 sector firms examine the Biotechnology segment in this 107-page report from The Wall Street Transcript. Order this Report

  1. Roundtable Forum - Investing in Biotechnology Stocks: George Huang, Stansberry & Associates; Dr. Raghuram Selvaraju, Hapoalim Securities USA, Inc.; Steven Silver, Standard & Poor's Equity Research

  2. Biotechnology Companies: Carol Werther, Summer Street Research Partners

  3. Off the Record: Off the Record asks company leadership which management teams in their sector they most respect for their ability to execute and generate shareholder value.

  4. CEO Interviews (average 2,500 words): Top management from 15 sector firms examine the outlook for their firm and sector. Firms interviewed include: Advaxis, Inc., Labopharm Inc., NeoStem, Inc., Polydex Pharmaceuticals Limited, Aeterna Zentaris Inc., Urigen Pharmaceuticals, Inc., AcquiSci Inc., Genmed Holding Corp., MDRNA, Inc., Nuvilex, Inc., Nuvo Research Inc., Ondine Biopharma Corporation, PURE Bioscience, WEX Pharmaceuticals, Inc., XOMA Ltd.

    Topics covered: Negative financing environment - Regulatory outlook - R&D spending outlook - M&A activity - Potential acquisition targets - Big Pharma interest in acquisitions - FDA approval process - Missed PDUFA dates - Molecular diagnostics growth area - Follow-on biologics - Activist shareholder action - Cost containment measures - More generic drug usage - IPO window - Shortage of cash - Expectation of more bankruptcies - Winners and losers - Investor interest - Stocks picks

    Companies covered: Genzyme (GENZ); Celgene (CELG); Gilead Sciences (GILD); Medivation (MDVN); Sequenom (SQNM); XenoPort (XNPT); ARYx Therapeutics (ARYX); Biogen Idec (BIIB); Dendreon (DNDN); Acorda Therapeutics (ACOR); Alexion (ALXN); Cardiome (CRME); Vertex Pharmaceuticals (VRTX); Avigen (AVGN); Amylin Pharmaceuticals (AMLN); Micromet (MITI); BioMarin Pharmaceuticals (BMRN); Myriad Genetics (MYGN).
    ORDER THIS REPORT NOW! CLICK HERE